These in vitro results confirmed the advantage of using drug delivery systems combined with transferrin targeting ligand, which significantly increased the cellular accumulation and antiproliferative activity of α-mangostin in cancer cells overexpressing Tf receptors. This evidence concerns the gene TF and cancer.